respiratory tract infection 7 (11.5%) 5 (8.5%) Convulsion 7 (11.5%) 3(5.1%) Source: Cowen and Company In 2015, GW initiated two Phase III trials in Lennox-Gastaut Syndrome. The first trial enrolled 171 patients, and the second enrolled 225. In the first LGS study, the patients were randomized 1:1 to 20mg/kg or placebo w